In a recent case the Madras High Court upheld Akebia Therapeutics’ appeal on its anaemia treatment patent, interpreting Section 59 to allow claim amendments from treatment methods to compositions, as long as they’re disclosed in the original application. The case underscores the significance of well-documented specifications in pharmaceutical patents.
Read more about Akebia’s patent for Anemia therapy gets fresh blood from CourtTag: Section 59 Patents Act
Claim Amendments within the Scope of Patent Specification are Permissible, the Delhi High Court reiterates
The Delhi High Court has reaffirmed that claim amendments falling within the scope of the original patent specification are permissible under Indian law. The judgment provides clarity on Section 59(1) of the Patents Act and sets important precedent for future patent amendment cases.
Read more about Claim Amendments within the Scope of Patent Specification are Permissible, the Delhi High Court reiteratesCourts Weigh on Inordinate Delay in Patent Orders and Scope of Claim Amendments
The Delhi and Madras High Courts recently set aside patent refusal orders, addressing inordinate delays and the scope of permissible claim amendments. These judgments clarify key patent law principles and reinforce procedural fairness in India.
Read more about Courts Weigh on Inordinate Delay in Patent Orders and Scope of Claim Amendments